|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Cost of goods sold (exclusive of depreciation and amortization) | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest expense, net | |||||
| Debt extinguishment loss | |||||
| Change in fair value of warrants | |||||
| Change in fair value of derivative liability | |||||
| Other income (loss), net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss attributable to common stockholders | |||||
| Weighted average of shares outstanding – basic (in shares) | |||||
| Weighted average of shares outstanding – diluted (in shares) | |||||
| Net loss attributable to common stockholders per share - basic (in dollars per share) | |||||
| Net loss attributable to common stockholders per share - diluted (in dollars per share) | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
Loading...